LIANY
Price
$0.42
Change
+$0.01 (+2.44%)
Updated
Jun 25 closing price
Capitalization
45.83M
47 days until earnings call
TRML
Price
$16.65
Change
-$0.34 (-2.00%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
436.45M
Interact to see
Advertisement

LIANY vs TRML

Header iconLIANY vs TRML Comparison
Open Charts LIANY vs TRMLBanner chart's image
LianBio
Price$0.42
Change+$0.01 (+2.44%)
Volume$5.28M
Capitalization45.83M
Tourmaline Bio
Price$16.65
Change-$0.34 (-2.00%)
Volume$7.51K
Capitalization436.45M
LIANY vs TRML Comparison Chart in %
Loading...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIANY vs. TRML commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIANY is a Hold and TRML is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (LIANY: $0.42 vs. TRML: $16.99)
Brand notoriety: LIANY and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIANY: 2495% vs. TRML: 113%
Market capitalization -- LIANY: $45.83M vs. TRML: $436.45M
LIANY [@Biotechnology] is valued at $45.83M. TRML’s [@Biotechnology] market capitalization is $436.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIANY’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • LIANY’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, LIANY is a better buy in the long-term than TRML.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRML’s TA Score shows that 4 TA indicator(s) are bullish.

  • TRML’s TA Score: 4 bullish, 6 bearish.

Price Growth

LIANY (@Biotechnology) experienced а +10.53% price change this week, while TRML (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

LIANY is expected to report earnings on Aug 12, 2025.

TRML is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($436M) has a higher market cap than LIANY($45.8M). LIANY YTD gains are higher at: 58.491 vs. TRML (-16.223).
LIANYTRMLLIANY / TRML
Capitalization45.8M436M11%
EBITDAN/A-98.41M-
Gain YTD58.491-16.223-361%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A249M-
Total DebtN/A196K-
TECHNICAL ANALYSIS
Technical Analysis
TRML
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KSA37.820.10
+0.27%
iShares MSCI Saudi Arabia ETF
BSMV20.580.01
+0.05%
Invesco BulletShares 2031 Muncpl Bd ETF
CGHM24.630.01
+0.02%
Capital Group Municipal High-Income ETF
ANGL29.02-0.02
-0.07%
VanEck Fallen Angel HiYld Bd ETF
QID26.28-0.12
-0.47%
ProShares UltraShort QQQ

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
+1.20%
SER - LIANY
69%
Closely correlated
+4.23%
GERN - LIANY
53%
Loosely correlated
-1.94%
TRML - LIANY
28%
Poorly correlated
+0.30%
OTLK - LIANY
23%
Poorly correlated
+1.69%
MTNB - LIANY
21%
Poorly correlated
+6.41%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+0.30%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
51%
Loosely correlated
-2.69%
STOK - TRML
48%
Loosely correlated
+2.61%
IPSC - TRML
45%
Loosely correlated
-4.74%
SYRE - TRML
45%
Loosely correlated
+2.01%
More